Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anus Neoplasms × Platinum × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Small Cell Lung Carcinoma 2 Non-squamous Non-small Cell Lung Cancer 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Sertoli-Leydig Cell Tumor 1 Ovarian gynandroblastoma 1 Ovarian Neoplasms 1 Non-squamous NSCLC 1 Non-small Cell Lung Cancer Metastatic 1 Lung Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Brain Neoplasms 1 Anus Neoplasms 1 Anal Canal Carcinoma 1 Advanced Esophagus Cancer 1

Interventions

Fluorouracil 4 Paclitaxel 3 Mitomycin 3 Capecitabine 3 Radiotherapy 2 Radiation 2 Cisplatin 2 Carboplatin 2 fludarabine 1 dehydroftorafur 1 avelumab 1 Taxes 1 Ritonavir 1 Probiotics 1 Prebiotics 1 Platinum 1 Oxaliplatin 1 Mitomycins 1 Interleukin-2 1 Indinavir 1 Immune Checkpoint Inhibitors 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Diathermy 1 Cyclophosphamide 1 Chemoradiotherapy 1 Cetuximab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡